Xida Pharmaceuticals Private Limited
About Xida Pharmaceuticals Private Limited
Data last updated:
Xida Pharmaceuticals Private Limited is a private limited company based in Behrampore, West Bengal, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 15 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2016PTC218612. Its GSTIN is 07AAACX2148M1Z3 (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Amitava Pal and Aditya Pal.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 111 Pilkhana Road Annie Appartment G – 2 3 Ranibagan, Behrampore, West Bengal, India – 742101.
As per the financials filed for FY 2021, the company reported a revenue of ₹5.74 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹89,468 (net margin -15.6%) and EBITDA of -₹88,971 (EBITDA margin -15.5%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address111 Pilkhana Road Annie Appartment G – 2 3 Ranibagan, Behrampore, West Bengal, India – 742101
- IndustryHealthcare, Other Hospital And Medical Care Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Xida Pharmaceuticals Private Limited
The main business activity of Xida Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Xida Pharmaceuticals Private Limited FY 2021 filings available
Xida Pharmaceuticals Private Limited reported revenue of ₹5.74 Lakh (down 74% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Xida Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 11% over three years, including a 74% fall in the latest year. EBITDA fell 176% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Xida Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹88,971 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹89,468 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Xida Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -15.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -15.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Xida Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Xida Pharmaceuticals Private Limited
Xida Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Symbselect Pharmaceuticals (OPC) Private Limited | ₹5.82 Lakh (FY 2025) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Ceflact Pharmaceuticals Private Limited | ₹5.82 Lakh (FY 2024) | •••• | •••• | 19.0% | •••• | Allahabad, Uttar Pradesh, India |
| Carolus Pharmaceuticals Private Limited | ₹5.82 Lakh (FY 2024) | •••• | •••• | -63.0% | •••• | New Delhi, Delhi, India |
| Sree Rakhadi Bio Pharmaceuticals Private Limited | ₹5.77 Lakh (FY 2019) | •••• | •••• | -23.0% | •••• | Hyderabad, Telangana, India |
| Rivisa Pharmaceuticals (OPC) Private Limited | ₹5.76 Lakh (FY 2025) | •••• | •••• | 23.0% | •••• | Hosur, Tamil Nadu, India |
| Xida Pharmaceuticals Private Limited this company | ₹5.74 Lakh (FY 2021) | •••• | •••• | -74.0% | •••• | Behrampore, West Bengal, India |
| Elowen Pharmaceuticals Private Limited | ₹5.69 Lakh (FY 2024) | •••• | •••• | 28463650.0% | •••• | Pune, Maharashtra, India |
| B.S.G.Chemicals and Pharmaceuticals Private Limited | ₹5.69 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Hyderabad, Telangana, India |
| Austinleekos Pharmaceuticals Private Limited | ₹5.67 Lakh (FY 2025) | •••• | •••• | •••• | Sadar, Odisha, India | |
| Pnbsalpena Pharmaceuticals Private Limited | ₹5.66 Lakh (FY 2024) | •••• | •••• | -83.0% | •••• | Pune, Maharashtra, India |
| Gonash Pharmaceuticals Private Limited | ₹5.66 Lakh (FY 2020) | •••• | •••• | •••• | Danapur, Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Xida Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Xida Pharmaceuticals Private Limited
Xida Pharmaceuticals Private Limited is audited by P M A S & ASSOCIATES LLP for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P M A S & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Xida Pharmaceuticals Private Limited
Xida Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amitava Pal Also directs: Xida Real Estate Private Limited, Ap9 Developers Private Limited | Director | 15 Dec 2016 | 9 Years 9 Months | Current |
| Aditya Pal Also directs: Xida Real Estate Private Limited, Ap9 Developers Private Limited | Director | 05 Feb 2018 | 8 Years 8 Months | Current |
Ownership and Shareholding of Xida Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Xida Pharmaceuticals Private Limited
Xida Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Xida Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Xida Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Xida Pharmaceuticals Private Limited
Xida Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Abhishek Devroy ceased to be Director on 05 Feb 2018.
Credit Ratings, Litigation & Regulatory Alerts for Xida Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Xida Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Xida Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Xida Pharmaceuticals Private Limited
Xida Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACX2148M1Z3 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Xida Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xida Pharmaceuticals Private Limited
Xida Pharmaceuticals is an active private limited company based in Behrampore, West Bengal, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 15 December 2016 (10+ years old) and is registered under CIN U51909WB2016PTC218612.
Xida Pharmaceuticals reported revenue of ₹5.74 Lakh for FY 2021 (down 74% YoY).
Xida Pharmaceuticals has 2 current directors:
- Amitava Pal - Director
- Aditya Pal - Director
Xida Pharmaceuticals reported a net loss of ₹89,468 (net margin -15.6%) and EBITDA of -₹88,971 (EBITDA margin -15.5%) for FY 2021, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Xida Pharmaceuticals is -11% over three years. In the latest year (FY 2021) revenue fell 74%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Xida Pharmaceuticals is 07AAACX2148M1Z3, registered in Delhi.
The CIN (Corporate Identification Number) of Xida Pharmaceuticals is U51909WB2016PTC218612. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xida Pharmaceuticals was incorporated on 15 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Xida Pharmaceuticals by revenue are Symbselect Pharmaceuticals (OPC) Private Limited, Ceflact Pharmaceuticals Private Limited, Carolus Pharmaceuticals Private Limited, Sree Rakhadi Bio Pharmaceuticals Private Limited, Rivisa Pharmaceuticals (OPC) Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Abhishek Devroy ceased to be Director on 05 Feb 2018. Aditya Pal was appointed as Director on 05 Feb 2018. Abhishek Devroy was appointed as Director on 15 Dec 2016. Xida Pharmaceuticals has 4 board changes on record in total.
The registered office of Xida Pharmaceuticals is at 111 Pilkhana Road Annie Appartment G – 2 3 Ranibagan, Behrampore, West Bengal, India – 742101.